IPI INSTITUTE FOR PROTEIN INNOVATION - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 87851352
Serial Number
87851352
Registration Number
6531115
Word Mark
IPI INSTITUTE FOR PROTEIN INNOVATION
Status
700 - Registered
Status Date
2021-10-19
Filing Date
2018-03-27
Registration Number
6531115
Registration Date
2021-10-19
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
241503, 241510, 261709 - Arrows formed by words, letters, numbers or punctuation. More than one arrow. Curved line(s), band(s) or bar(s).
Published for Opposition Date
2019-01-01
Attorney Name
Law Office Assigned Location Code
M50
Employee Name
LEWIS, SHAILA E
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text
"INSTITUTE FOR PROTEIN INNOVATION"
Description of Mark
The mark consists of the letters "IPI" with two stylized letter "Is" to the left of the words "Institute for Protein Innovation" where "Institute for" is in a smaller font and above "Protein" and "Protein" is in the same font and above "Innovation." For the stylized letter "Is", the first "I" is a downward facing arrow and the second "I" is an upward facing arrow. The non-arrow end of each stylized "I" is connected to the letter "P" using a thin curved line, where the top of the first stylized letter "I" is connected to the top of the "P" and the base of the second stylized letter "I" is connected to the base of the letter "P".
Goods and Services
Pharmaceuticals, namely, antibodies and antibody fragments for use in the prevention and treatment of disorders of metabolism, the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, and the genitourinary system; Therapeutic antibodies for use as immunotherapeutic agents; Pharmaceuticals, namely, antibodies and antibody fragments for the treatment of fibrotic and inflammatory disorders; Pharmaceuticals, namely, antibodies and antibody fragments for use in dermatology, nephrology, hepatology, rheumatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceuticals, namely, antibodies and antibody fragments for use as antiviral, antibacterial, or anti-fungal agents
Pseudo Mark
INSTITUTE FOR PROTEIN INNOVATION INSTITUTE FOR PROTEIN INNOVATION
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-04-03
Primary Code
005
First Use Anywhere Date
2020-10-27
First Use In Commerce Date
2020-10-27
Current Trademark Owners
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Trevor P. Schmidt
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2018-03-30NEW APPLICATION ENTERED IN TRAM
2018-04-03NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2018-04-04NOTICE OF DESIGN SEARCH CODE E-MAILED
2018-04-04TEAS CHANGE OF CORRESPONDENCE RECEIVED
2018-07-12ASSIGNED TO EXAMINER
2018-07-19NON-FINAL ACTION WRITTEN
2018-07-19NON-FINAL ACTION E-MAILED
2018-07-19NOTIFICATION OF NON-FINAL ACTION E-MAILED
2018-10-30TEAS RESPONSE TO OFFICE ACTION RECEIVED
2018-10-30TEAS RESPONSE TO OFFICE ACTION RECEIVED
2018-10-30TEAS CHANGE OF CORRESPONDENCE RECEIVED
2018-10-30TEAS CHANGE OF CORRESPONDENCE RECEIVED
2018-11-09ASSIGNED TO LIE
2018-11-19CORRESPONDENCE RECEIVED IN LAW OFFICE
2018-11-19TEAS/EMAIL CORRESPONDENCE ENTERED
2018-11-19APPROVED FOR PUB - PRINCIPAL REGISTER
2018-12-12NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2019-01-01PUBLISHED FOR OPPOSITION
2019-01-01OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2019-02-26NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2019-03-08TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2019-03-08ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2019-04-08ASSIGNED TO EXAMINER
2019-08-23TEAS EXTENSION RECEIVED
2019-08-23EXTENSION 1 FILED
2019-08-23EXTENSION 1 GRANTED
2019-08-27NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2020-02-13TEAS EXTENSION RECEIVED
2020-02-13EXTENSION 2 FILED
2020-02-13EXTENSION 2 GRANTED
2020-02-15NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2020-08-25TEAS EXTENSION RECEIVED
2020-08-25EXTENSION 3 FILED
2020-08-25EXTENSION 3 GRANTED
2020-08-27NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2021-02-05TEAS EXTENSION RECEIVED
2021-02-05EXTENSION 4 FILED
2021-02-05EXTENSION 4 GRANTED
2021-02-09NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2021-07-13TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2021-07-13ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2021-07-13TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
2021-07-13TEAS CHANGE OF CORRESPONDENCE RECEIVED
2021-08-18TEAS STATEMENT OF USE RECEIVED
2021-08-23CASE ASSIGNED TO INTENT TO USE PARALEGAL
2021-08-18USE AMENDMENT FILED
2021-08-25STATEMENT OF USE PROCESSING COMPLETE
2021-09-16ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
2021-09-17NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
2021-10-19REGISTERED-PRINCIPAL REGISTER